49083-9
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
Active
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
49083-9 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel | |||
Indent46446-1 | Record ID section Set NAACCR v.11 | |||
Indent Indent21827-1 | Transmitted record type NAACCR message | |||
Indent Indent42023-2 | NAACCR facility identification system coding system | |||
Indent Indent21830-5 | Version NAACCR message | |||
Indent Indent21829-7 | Institution data source Registry message | |||
Indent Indent21831-3 | Unique tumor case ID Cancer | |||
Indent Indent42022-4 | NAACCR hospital tumor registration.permanent [Identifier] | |||
Indent46439-6 | Demographic section Set NAACCR v.11 | |||
Indent Indent21832-1 | Coding system 1970/80/90 Census tract at cancer diagnosis | |||
Indent Indent21833-9 | Alternate census tract at cancer diagnosis | |||
Indent Indent21851-1 | Address at cancer diagnosis | |||
Indent Indent21852-9 | Census tract certainty 1970and80and90 | |||
Indent Indent42026-5 | Census tract certainty 2000 | |||
Indent Indent21835-4 | Coding system.current Race | |||
Indent Indent21836-2 | Coding system.original Race | |||
Indent Indent21837-0 | Hispanic origin Best estimate | |||
Indent Indent21838-8 | Ethnicity Computed | |||
Indent Indent21839-6 | Derivation method Computed Ethnicity | |||
Indent Indent21840-4 | Sex [NAACCR v.11] | |||
Indent Indent21841-2 | Age at cancer diagnosis | a | ||
Indent Indent21842-0 | Birthplace | |||
Indent Indent21843-8 | History of Usual occupation | |||
Indent Indent21844-6 | History of Usual industry | |||
Indent Indent21845-3 | Source of information Usual occupational Hx | |||
Indent Indent21846-1 | Source of information Usual industry Hx | |||
Indent Indent21847-9 | Usual occupation Narrative | |||
Indent Indent21848-7 | Usual industry Narrative | |||
Indent Indent21849-5 | Coding system Occupational and Industry Hx | |||
Indent Indent21850-3 | Family history of Cancer Narrative | |||
Indent Indent39810-7 | RuralUrban continuum 1993 | |||
Indent Indent42125-5 | RuralUrban continuum 2000 | |||
Indent Indent42024-0 | NAACCR hispanic identification algorithm hispanic origin Derived | |||
Indent Indent42025-7 | NAACCR Indian Health Service linkage | |||
Indent Indent53720-9 | Race NAPIIA | |||
Indent Indent42027-3 | Geographic information system coordinate quality Cancer | |||
Indent Indent49084-7 | Census block group 1970and80and90 | |||
Indent46438-8 | Cancer identification section Set NAACCR v.11 | |||
Indent Indent21853-7 | Sequence number central.patient Cancer | |||
Indent Indent21854-5 | Date first Dx Cancer | |||
Indent Indent21855-2 | Primary site Cancer | |||
Indent Indent21856-0 | Histology ICD-O-2 Cancer | |||
Indent Indent21857-8 | Behavior ICD-O-2 Cancer | |||
Indent Indent31205-8 | Histology ICD-O-3 Cancer | |||
Indent Indent31206-6 | Behavior ICD-O-3 Cancer | |||
Indent Indent21858-6 | Grade Cancer | |||
Indent Indent42129-7 | Site coding system.current Cancer site | |||
Indent Indent21859-4 | Coding system.original Cancer site | |||
Indent Indent42034-9 | Coding system.current Cancer morphology | |||
Indent Indent21860-2 | Coding system.original Cancer morphology | |||
Indent Indent21861-0 | Dx confirmed by Cancer | |||
Indent Indent21862-8 | Source of document used to abstract Cancer | |||
Indent Indent21863-6 | Date last screened Cancer | |||
Indent Indent21864-4 | Most recent screening result for Cancer | |||
Indent Indent42035-6 | Casefinding source Cancer | |||
Indent Indent42028-1 | NAACCR ambiguous terminology as basis for diagnosis | |||
Indent Indent42029-9 | Date of conclusive diagnosis Cancer | |||
Indent Indent42030-7 | Multiple tumors reported as single primary Cancer | |||
Indent Indent42031-5 | Date of diagnosis of multiple tumors Cancer | |||
Indent Indent42032-3 | Number of tumors at diagnosis Cancer | {#} | ||
Indent Indent42033-1 | Number of tumors and histologies | {#} | ||
Indent46443-8 | Hospital-specific section Set NAACCR v.11 | |||
Indent Indent21865-1 | Hospital.reporting [Identifier] Cancer | |||
Indent Indent42106-5 | Archive facility identification number Cancer | |||
Indent Indent21866-9 | Patient ID.hospital | |||
Indent Indent21867-7 | Sequence number.hospital Cancer | |||
Indent Indent21868-5 | User ID.hospital assigned Abstractor | |||
Indent Indent21869-3 | Hospital admission.first contact [Date and time] Cancer | |||
Indent Indent21870-1 | Date of inpatient admission Cancer | |||
Indent Indent21871-9 | Date of inpatient discharge Cancer | |||
Indent Indent21872-7 | Relationship between this hospital and cancer Dx | |||
Indent Indent21873-5 | Year first seen at this hospital for [Date] Cancer | {yyyy} | ||
Indent Indent21874-3 | Cancer conference.presentation status at reporting facility | |||
Indent Indent21875-0 | Cancer conference [Date and time] | |||
Indent Indent21876-8 | Surgery procedure for primary site at facility.YYY Cancer | |||
Indent Indent21877-6 | Surgery procedure for regional nodes at facility.YYY Cancer | |||
Indent Indent21878-4 | Other regional disease at facility.YYY most definitive procedure Cancer | |||
Indent Indent21879-2 | Surgery.regional nodes examined at facility.YYY most definitive procedure [#] Surgery Cancer | |||
Indent Indent21880-0 | Radiation treatment therapy Cancer | |||
Indent Indent21881-8 | Chemotherapy treatment at facility.YYY Cancer | |||
Indent Indent21882-6 | Hormone treatment at facility.YYY Cancer | |||
Indent Indent21883-4 | Transplant treatment at facility.YYY Cancer | |||
Indent Indent21884-2 | Other treatment at facility.YYY Cancer | |||
Indent Indent21885-9 | Surgery.not cancer treatment at facility.YYY | |||
Indent Indent42124-8 | Palliative procedure at this facility Cancer | |||
Indent46448-7 | Stage/prognostic factors section Set NAACCR v.11 | |||
Indent Indent39806-5 | Summary stage at Dx 2000 revised Cancer | |||
Indent Indent21887-5 | SEER summary stage 1977 Cancer | |||
Indent Indent21888-3 | Summary stage abbreviated at Dx Cancer | |||
Indent Indent21889-1 | Size Tumor | mm | ||
Indent Indent21890-9 | Extension Cancer | |||
Indent Indent21891-7 | Extent of disease Prostate cancer | |||
Indent Indent21892-5 | Lymph node involvement Cancer | |||
Indent Indent21893-3 | Regional lymph nodes positive [#] Specimen | {#} | ||
Indent Indent21894-1 | Regional lymph nodes examined [#] Specimen | {#} | ||
Indent Indent21895-8 | Extent of disease.NAACCR.old 13 digit | |||
Indent Indent21896-6 | Extent of disease.NAACCR.old 2 digit | |||
Indent Indent21897-4 | Extent of disease.NAACCR.old 4 digit | |||
Indent Indent21898-2 | Version used Extent of disease coding system | |||
Indent Indent21899-0 | Primary tumor.pathology Cancer | |||
Indent Indent21900-6 | Regional lymph nodes.pathology [Class] Cancer | |||
Indent Indent21901-4 | Distant metastases.pathology [Class] Cancer | |||
Indent Indent21902-2 | Stage group.pathology Cancer | |||
Indent Indent21903-0 | Descriptor.pathology Cancer Narrative | |||
Indent Indent21904-8 | Stager.pathology Cancer | |||
Indent Indent21905-5 | Primary tumor.clinical [Class] Cancer | |||
Indent Indent21906-3 | Regional lymph nodes.clinical [Class] Cancer | |||
Indent Indent21907-1 | Distant metastases.clinical [Class] Cancer | |||
Indent Indent21908-9 | Stage group.clinical Cancer | |||
Indent Indent21909-7 | Descriptor.clinical Cancer Narrative | |||
Indent Indent21910-5 | Stager.clinical Cancer | |||
Indent Indent21917-0 | Version used [Identifier] TNM classification | |||
Indent Indent21919-6 | Date 1st positive Bx Cancer | |||
Indent Indent21920-4 | Site of distant metastasis Cancer | |||
Indent Indent21921-2 | Pediatric stage Cancer | |||
Indent Indent21922-0 | Coding system used Cancer pediatric staging | |||
Indent Indent21923-8 | Pediatric cancer stager | |||
Indent Indent21924-6 | Tumor marker Cancer | |||
Indent Indent42079-4 | Tumor size.collaborative staging | mm;cm | ||
Indent Indent42080-2 | Extension collaborative staging Cancer | |||
Indent Indent42081-0 | Collaborative staging tumor size extension evaluation Cancer | |||
Indent Indent42082-8 | Collaborative staging lymph nodes Cancer | |||
Indent Indent42083-6 | Collaborative staging regional nodes evaluation Cancer | |||
Indent Indent42084-4 | Collaborative staging metastasis at diagnosis Cancer | |||
Indent Indent42085-1 | Collaborative staging metastasis evaluation Cancer | |||
Indent Indent42086-9 | Collaborative staging site-Specific factor 1 Cancer | |||
Indent Indent42087-7 | Collaborative staging site-Specific factor 2 Cancer | |||
Indent Indent42088-5 | Collaborative staging site-Specific factor 3 Cancer | |||
Indent Indent42089-3 | Collaborative staging site-Specific factor 4 Cancer | |||
Indent Indent42090-1 | Collaborative staging site-Specific factor 5 Cancer | |||
Indent Indent42091-9 | Collaborative staging site-Specific factor 6 Cancer | |||
Indent Indent42094-3 | Derived American Joint Committee on Cancer T Derived | |||
Indent Indent42095-0 | Derived American Joint Committee on Cancer T descriptor | |||
Indent Indent21911-3 | Primary tumor.other [Class] Cancer | |||
Indent Indent42096-8 | Derived American Joint Committee on Cancer N | |||
Indent Indent42097-6 | Derived American Joint Committee on Cancer N descriptor | |||
Indent Indent42098-4 | Derived American Joint Committee on Cancer M | |||
Indent Indent42099-2 | Derived American Joint Committee on Cancer M descriptor | |||
Indent Indent42100-8 | Derived American Joint Committee on Cancer stage group | |||
Indent Indent42101-6 | Derived SEER summary stage 1977 Cancer | |||
Indent Indent42102-4 | Derived SEER summary stage 2000 Cancer | |||
Indent Indent42103-2 | Derived American Joint Committee on Cancer conversion method | |||
Indent Indent42104-0 | Derived SEER summary stage 1977 conversion method Cancer | |||
Indent Indent42105-7 | Derived SEER summary stage 2000 conversion method Cancer | |||
Indent Indent42126-3 | Comorbidities and complications 1 | |||
Indent Indent42107-3 | Comorbidities and complications 2 | |||
Indent Indent42108-1 | Comorbidities and complications 3 | |||
Indent Indent42109-9 | Comorbidities and complications 4 | |||
Indent Indent42110-7 | Comorbidities and complications 5 | |||
Indent Indent42111-5 | Comorbidities and complications 6 | |||
Indent Indent42092-7 | Collaborative staging version.first Cancer | |||
Indent Indent42093-5 | Collaborative staging version.latest Cancer | |||
Indent Indent42112-3 | Comorbidities and complications 7 | |||
Indent Indent42113-1 | Comorbidities and complications 8 | |||
Indent Indent42114-9 | Comorbidities and complications 9 | |||
Indent Indent42115-6 | Comorbidities and complications 10 | |||
Indent Indent42116-4 | ICD revision comorbidities Cancer | |||
Indent Indent21912-1 | Regional lymph nodes.other [Class] Cancer | |||
Indent Indent21913-9 | Distant metastases.other [Class] Cancer | |||
Indent Indent21914-7 | Stage group.other Cancer | |||
Indent Indent21915-4 | Stager.other Cancer | |||
Indent Indent21916-2 | Descriptor.other Cancer Narrative | |||
Indent Indent21918-8 | Other staging classification Cancer Narrative | |||
Indent46452-9 | Treatment-1st course section Set NAACCR v.11 | |||
Indent Indent42036-4 | Cancer-Directed surgery at this facility 98-02 | |||
Indent Indent42037-2 | Scope of regional lymph node surgery at this facility 98-02 Cancer | |||
Indent Indent42038-0 | Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02 Cancer | |||
Indent Indent21925-3 | Date 1st surgery treatment Cancer | |||
Indent Indent39808-1 | Date 1st most definitive surgery treatment for Cancer | |||
Indent Indent42117-2 | Date of surgical discharge Cancer | |||
Indent Indent21926-1 | Date 1st radiation treatment Cancer | |||
Indent Indent42120-6 | Date radiation ended Cancer | |||
Indent Indent39809-9 | Date 1st systemic treatment Cancer | |||
Indent Indent21927-9 | Date 1st chemotherapy treatment Cancer | |||
Indent Indent21928-7 | Date 1st hormone treatment Cancer | |||
Indent Indent21929-5 | Date 1st immunotherapy treatment Cancer | |||
Indent Indent21930-3 | Date 1st other treatment Cancer | |||
Indent Indent21931-1 | Date 1st cancer treatment (any).SEERS | |||
Indent Indent21932-9 | Date 1st cancer treatment (any).COC | |||
Indent Indent21933-7 | Date non cancer directed surgery treatment as part of 1st cancer | |||
Indent Indent21934-5 | Surgery site.primary Cancer | |||
Indent Indent21935-2 | Surgery scope Cancer | |||
Indent Indent21936-0 | Surgery.other regional disease Cancer | |||
Indent Indent21937-8 | Surgery regional nodes examined [#] Cancer | |||
Indent Indent21938-6 | Surgical approach | |||
Indent Indent21939-4 | Surgical margins cancer involvement | |||
Indent Indent21940-2 | Surgery reconstruction | |||
Indent Indent21941-0 | Reason for no cancer directed surgery | |||
Indent Indent21942-8 | Non cancer directed surgery summary | |||
Indent Indent21943-6 | Radiation treatment Cancer | |||
Indent Indent21944-4 | Lung and leukemia CNS radiation status Cancer | |||
Indent Indent21945-1 | Surgery-radiation sequence Cancer | |||
Indent Indent21946-9 | Chemotherapy treatment Cancer | |||
Indent Indent21947-7 | Hormone treatment Cancer | |||
Indent Indent21948-5 | Biological response modifier treatment Cancer | |||
Indent Indent21949-3 | Other treatment Cancer | |||
Indent Indent21950-1 | Reason for no radiation treatment Cancer | |||
Indent Indent21951-9 | Reason for no chemotherapy treatment Cancer | |||
Indent Indent21952-7 | Reason for no hormone treatment Cancer | |||
Indent Indent21953-5 | Coding system for treatment [Identifier] Cancer | |||
Indent Indent21954-3 | Protocol eligibility status Cancer | |||
Indent Indent21955-0 | Source of protocol in which patient enrolled Cancer | |||
Indent Indent21956-8 | Referred to support services Cancer | |||
Indent Indent21957-6 | Method for calculating time interval of first course of treatment | |||
Indent Indent21958-4 | Regional radiation treatment Dose | cGy | ||
Indent Indent21959-2 | Number of radiation treatment | {#} | ||
Indent Indent21960-0 | Duration first episode Radiation treatment | d | ||
Indent Indent21961-8 | Organ target(s) First episode Radiation treatment | |||
Indent Indent21962-6 | Where performed Radiation treatment | |||
Indent Indent21963-4 | Curative intent of treatment Radiation treatment | |||
Indent Indent21964-2 | Modality Radiation treatment | |||
Indent Indent42128-9 | Boost radiation treatment modality Radiation treatment | |||
Indent Indent42119-8 | Boost radiation dose [Energy/mass] | cGy | ||
Indent Indent42039-8 | Systemic therapy/surgery sequence Cancer | |||
Indent Indent21965-9 | Completion status Radiation treatment | |||
Indent Indent21966-7 | Regional outcomes of Radiation treatment | |||
Indent Indent21968-3 | Surgery Cancer | |||
Indent Indent21969-1 | Dx/Stage Procedure | |||
Indent Indent42040-6 | Cancer-Directed surgery 98-02 [Anatomy] | |||
Indent Indent42041-4 | Scope of regional lymph node surgery 98-02 Cancer | |||
Indent Indent42042-2 | Surgery of other regional site(s), distant site(s) or distant lymph nodes 98-02 Cancer | |||
Indent46453-7 | Treatment-subsequent and other section Set NAACCR v.11 | |||
Indent Indent21970-9 | 2nd course treatment start date Cancer Rx | |||
Indent Indent21971-7 | 2nd course treatment Cancer Rx | |||
Indent Indent42043-0 | 2nd course surgery Cancer Rx | |||
Indent Indent42044-8 | 2nd course radiation Cancer Rx | |||
Indent Indent42045-5 | 2nd course chemotherapy Cancer Rx | |||
Indent Indent42046-3 | 2nd course hormonal therapy Cancer Rx | |||
Indent Indent42047-1 | 2nd course biological reponse modifier therapy Cancer Rx | |||
Indent Indent42048-9 | 2nd course other therapy Cancer Rx | |||
Indent Indent21973-3 | 3rd course treatment Cancer Rx | |||
Indent Indent42049-7 | 3rd course surgery Cancer Rx | |||
Indent Indent42050-5 | 3rd course radiation Cancer Rx | |||
Indent Indent42051-3 | 3rd course chemotherapy Cancer Rx | |||
Indent Indent42052-1 | 3rd course hormonal therapy Cancer Rx | |||
Indent Indent42053-9 | 3rd course biological response modifier therapy Cancer Rx | |||
Indent Indent42054-7 | 3rd course other therapy Cancer Rx | |||
Indent Indent42055-4 | 4th course Surgery Cancer Rx | |||
Indent Indent42056-2 | 4th course radiation Cancer Rx | |||
Indent Indent42057-0 | 4th course chemotherapy Cancer Rx | |||
Indent Indent42058-8 | 4th course hormonal therapy Cancer Rx | |||
Indent Indent42059-6 | 4th course biological response modifier therapy Cancer Rx | |||
Indent Indent42060-4 | 4th course other therapy Cancer Rx | |||
Indent Indent21974-1 | Surgery reconstruction Cancer Rx | |||
Indent46440-4 | Edit overrides/Conversion history/System admin section Set NAACCR v.11 | |||
Indent Indent42067-9 | Summary stage and regional lymph nodes positive override flag Cancer case | |||
Indent Indent42068-7 | Summary stage and TNM-N override flag Cancer case | |||
Indent Indent42069-5 | Summary stage and TNM-M override flag Cancer case | |||
Indent Indent42070-3 | Summary stage and distant metastasis 1 override flag Cancer case | |||
Indent Indent42071-1 | Accession number and class of case and sequence number override flag Cancer case | |||
Indent Indent42072-9 | Hospital sequence number and diagnostic confirmation override flag Cancer case | |||
Indent Indent42073-7 | Commission on Cancer (COC) site and type override flag | |||
Indent Indent42074-5 | Hospital sequence and site override flag Cancer case | |||
Indent Indent42075-2 | Primary site and TNM-stage group override flag Cancer case | |||
Indent Indent21991-5 | Age and Site and Morphology override flag Cancer case | |||
Indent Indent21992-3 | Sequence numberanddiagnosis confirm override flag Cancer case | |||
Indent Indent21993-1 | Site and laterality and sequence number override flag Cancer case | |||
Indent Indent21994-9 | Surgery and diagnosis confirm override flag Cancer case | |||
Indent Indent21995-6 | Siteandtype override flag Cancer case | |||
Indent Indent21996-4 | Histology override flag Cancer case | |||
Indent Indent21997-2 | Report source override flag Cancer case | |||
Indent Indent21998-0 | Ill defined site override flag Cancer case | |||
Indent Indent21999-8 | Leukemia and lymphoma override flag Cancer case | |||
Indent Indent22000-4 | Site and behavior override flag Cancer case | |||
Indent Indent22001-2 | Site and extent of disease and diagnosis date override flag Cancer case | |||
Indent Indent22002-0 | Site and laterality and extent of disease override flag Cancer case | |||
Indent Indent22003-8 | Site and laterality and morphology override flag Cancer case | |||
Indent Indent21988-1 | Site.ICD-O-1 Cancer | |||
Indent Indent21989-9 | Morphology.ICD-O-1 Cancer | |||
Indent Indent42066-1 | Histology ICD-O-1 Cancer | |||
Indent Indent42632-0 | Grade ICD-O-1 Cancer | |||
Indent Indent21990-7 | ICD-O-1 to ICD-O-2 conversion method | |||
Indent Indent22004-6 | CRC checksum | |||
Indent Indent22005-3 | Date case completed Cancer case | |||
Indent Indent22006-1 | Date case last changed Cancer case | |||
Indent Indent22007-9 | Date case report exported Cancer case | |||
Indent Indent22011-1 | Coding system.current.SEER [Identifier] Cancer registry | |||
Indent Indent22012-9 | Coding system.original.SEER [Identifier] Cancer registry | |||
Indent Indent22013-7 | Coding system.current. Commission on Cancer (COC) [Identifier] Cancer registry | |||
Indent Indent22014-5 | Coding system.original.Commission on Cancer (COC) [Identifier] Cancer registry | |||
Indent Indent22015-2 | Follow-up expectation Cancer case | |||
Indent Indent22016-0 | SEER record number Cancer case | |||
Indent Indent22017-8 | State defined narrative Narrative | |||
Indent Indent22008-7 | Date case report received Cancer case | |||
Indent Indent22009-5 | Date case report loaded Cancer case | |||
Indent Indent22010-3 | Date tumor record available Cancer case | |||
Indent Indent42076-0 | ICD-O-2 to ICD-O-3 conversion method | |||
Indent46441-2 | Follow-up/Recurrence/Death section Set NAACCR v.11 | |||
Indent Indent21975-8 | Date last contact | |||
Indent Indent53719-1 | Date of death - Canada | |||
Indent Indent31210-8 | Vital status NAACCR | |||
Indent46447-9 | Special use section Set NAACCR v.11 | |||
Indent Indent22017-8 | State defined narrative Narrative | |||
Indent46445-3 | Patient-confidential section Set NAACCR v.11 | |||
Indent Indent22018-6 | Military patient number | |||
Indent Indent42077-8 | Patient phone number | |||
Indent Indent42127-1 | Name of follow-up contact | |||
Indent Indent42078-6 | Follow-up contact supplemental information | |||
Indent Indent42130-5 | Latitude | |||
Indent Indent42131-3 | Longitude | |||
Indent46442-0 | Hospital-confidential section Set NAACCR v.11 | |||
Indent Indent22023-6 | Last follow-up hospital [Identifier] Cancer registry | |||
Indent Indent22024-4 | Following registry [Identifier] Cancer registry | |||
Indent Indent22021-0 | Institution referred from Cancer registry | |||
Indent Indent22022-8 | Institution referred to Cancer registry | |||
Indent46444-6 | Other-confidential section Set NAACCR v.11 | |||
Indent Indent22025-1 | Physician managing [Identifier] | |||
Indent Indent22026-9 | Physician follow up [Identifier] | |||
Indent Indent22027-7 | Surgeon primary [Identifier] | |||
Indent Indent22028-5 | Physician [Identifier] | |||
Indent46449-5 | Text-diagnosis section Set NAACCR v.11 | |||
Indent Indent22029-3 | Physical exam Narrative | |||
Indent Indent22030-1 | Xray/Scan.total Narrative | |||
Indent Indent22031-9 | Scopic exam Narrative | |||
Indent Indent22032-7 | Lab tests Narrative | |||
Indent Indent22033-5 | Operations (?).total Narrative | |||
Indent Indent22034-3 | Pathology report Cancer Narrative | |||
Indent Indent22035-0 | Primary site Cancer Narrative | |||
Indent Indent22036-8 | Histology Cancer Narrative | |||
Indent Indent22037-6 | Staging Cancer Narrative | |||
Indent46451-1 | Text-treatment section Set NAACCR v.11 | |||
Indent Indent22038-4 | Surgery treatment Cancer Narrative | |||
Indent Indent22039-2 | Radiation beam treatment Cancer Narrative | |||
Indent Indent22040-0 | Radiation other treatment Cancer Narrative | |||
Indent Indent22041-8 | Chemotherapy treatment Cancer Narrative | |||
Indent Indent22042-6 | Hormone treatment Cancer Narrative | |||
Indent Indent22043-4 | Transplant treatment Cancer Narrative | |||
Indent Indent22044-2 | Other treatment Cancer Narrative | |||
Indent46450-3 | Text-miscellaneous section Set NAACCR v.11 | |||
Indent Indent22045-9 | Remarks recorded Cancer Narrative | |||
Indent Indent22046-7 | Place of 1st Dx [Location] Cancer Narrative |
Fully-Specified Name
- Component
- North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
- Property
- -
- Time
- Pt
- System
- ^Patient
- Scale
- -
- Method
Additional Names
- Short Name
- NAACCR v 11 Pnl
Basic Attributes
- Class
- PANEL.TUMRRGT
- Type
- Clinical
- First Released
- Version 2.21
- Last Updated
- Version 2.63
- Order vs. Observation
- Order
- Panel Type
- Panel
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Panel de la versión 11 de la Asociación Norteamericana de Registros Centrales del Cáncer, Inc (NAACCR, Inc): |
it-IT | Italian (Italy) | North American Association of Central Cancer Registries, Inc (NAACCR, Inc), panel versione 11: Synonyms: paziente Punto nel tempo (episodio) Registro tumori Set di prescrizione registro tumori |
pt-BR | Portuguese (Brazil) | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) painel: Synonyms: ; |
ru-RU | Russian (Russian Federation) | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) версия 11 панель: Synonyms: Точка во времени; |
zh-CN | Chinese (China) | NAACCR 11 版组套: Synonyms: NAACCR 11 版组套(组合、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=49083-9 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/49083-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright